問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Kaohsiung Medical Univeristy Chung-Ho Memorial Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2014-04-15 - 2017-12-31
Condition/Disease
Antidote for dabigatran
Test Drug
Idarucizumab (BI 655075)
Participate Sites5Sites
Terminated5Sites
2014-06-01 - 2017-05-31
Participate Sites9Sites
Terminated9Sites
2008-12-01 - 2011-07-31
Participate Sites14Sites
Terminated14Sites
2006-08-01 - 2009-01-31
2007-10-01 - 2008-10-31
Participate Sites6Sites
Terminated6Sites
2009-07-01 - 2012-08-31
2010-02-01 - 2011-10-30
Participate Sites11Sites
Terminated11Sites
2010-05-01 - 2013-12-31
Participate Sites15Sites
Terminated15Sites
2010-07-01 - 2012-12-31
Participate Sites10Sites
Terminated10Sites
2009-10-01 - 2012-01-31
Study ended10Sites
全部
